Business Description
Beijing Northland Biotech Co Ltd
ISIN : CNE1000044K7
Total Employee Number:
193Compare
Compare
Traded in other countries / regions
920047.China IPO Date
2020-11-24Description
Beijing Northland Biotech Co Ltd is engaged in technology transfer, technical services, production and sales of ophthalmic drugs, contract manufacturing, and contract research and development. The company's independently developed biopharmaceutical, NL003, has completed Phase III clinical trials this year.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.27 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | -1.93 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 11.01 | |||||
Beneish M-Score | -3.17 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.3 | |||||
3-Year EBITDA Growth Rate | 10.4 | |||||
3-Year EPS without NRI Growth Rate | 8.5 | |||||
3-Year FCF Growth Rate | -39.1 | |||||
3-Year Book Growth Rate | 9.5 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 15.79 | |||||
9-Day RSI | 26.35 | |||||
14-Day RSI | 33.04 | |||||
3-1 Month Momentum % | 4.99 | |||||
6-1 Month Momentum % | -20.42 | |||||
12-1 Month Momentum % | -32.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.7 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 1.51 | |||||
Days Inventory | 194.94 | |||||
Days Sales Outstanding | 14.89 | |||||
Days Payable | 404.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.1 | |||||
Shareholder Yield % | -1.98 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.21 | |||||
Operating Margin % | -109.66 | |||||
Net Margin % | -105.94 | |||||
EBITDA Margin % | -107.99 | |||||
FCF Margin % | -143.93 | |||||
OCF Margin % | -20.51 | |||||
ROE % | -22.6 | |||||
ROA % | -13.3 | |||||
ROIC % | -19.03 | |||||
3-Year ROIIC % | 9.32 | |||||
ROC (Joel Greenblatt) % | -30.34 | |||||
ROCE % | -16.08 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 29.91 | |||||
PS Ratio | 70.78 | |||||
PB Ratio | 17.21 | |||||
Price-to-Tangible-Book | 19.46 | |||||
EV-to-EBIT | -69.16 | |||||
EV-to-EBITDA | -69.16 | |||||
EV-to-Revenue | 74.68 | |||||
EV-to-FCF | -51.89 | |||||
Price-to-GF-Value | 1.01 | |||||
Earnings Yield (Greenblatt) % | -1.45 | |||||
FCF Yield % | -2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Northland Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 59.648 | ||
| EPS (TTM) (Â¥) | -0.242 | ||
| Beta | 0.9009 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 0.88 | ||
| Volatility % | 49.89 | ||
| 14-Day RSI | 33.04 | ||
| 14-Day ATR (Â¥) | 0.751078 | ||
| 20-Day SMA (Â¥) | 16.8765 | ||
| 12-1 Month Momentum % | -32.62 | ||
| 52-Week Range (Â¥) | 15.52 - 35.2 | ||
| Shares Outstanding (Mil) | 274.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Northland Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Northland Biotech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Beijing Northland Biotech Co Ltd Frequently Asked Questions
What is Beijing Northland Biotech Co Ltd(BJSE:920047)'s stock price today?
The current price of BJSE:920047 is ¥15.57. The 52 week high of BJSE:920047 is ¥35.20 and 52 week low is ¥15.52.
When is next earnings date of Beijing Northland Biotech Co Ltd(BJSE:920047)?
The next earnings date of Beijing Northland Biotech Co Ltd(BJSE:920047) is .
Does Beijing Northland Biotech Co Ltd(BJSE:920047) pay dividends? If so, how much?
Beijing Northland Biotech Co Ltd(BJSE:920047) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Beijing Northland Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers